Induced pluripotent stem cells for development of cancer immunotherapy - A viable idea for less toxic treatment

Authors

  • Prof. Binafsha Manzoor Syed

DOI:

https://doi.org/10.38106/LMRJ.2022.4.2-01

Keywords:

Cancer management, induced pleuripotent stem cells, monoclonal antibodies

Abstract

Induced pluripotent stem cells were introduced by Prof. Yamanaka and now being studied in all stem cells related treatment methods. Cancer immunotherapy is now part of targeted therapy and showing promising results, however the cost of treatment and tagged risk of side effects making it difficult for patients. Thus use of induced pluripotent stem cells to grow into plasma cells and produce antibodies against cancer targets will be a breakthrough in cancer management

 

Downloads

Published

2022-06-29